Font: Financial Modeling Prep • May 15, 2026
Analyst firm H.C. Wainwright raises its price target for NeuroPace to $20.00. This new target represents a potential 32.54% upside from its trading price of $15.09 at the time. NeuroPace is a medical device company that develops and markets a system to treat neurological disorders, such as epilepsy.
The positive analyst outlook follows a strong first-quarter 2026 performance. As highlighted by Zacks, NeuroPace reports total revenues of $22.1 million and a smaller adjusted loss of $0.13 per share. This is an improvement from the $0.18 per share loss in the same period last year, showing better financial control.
A key driver for this growth is the company's RNS System. Sales for this system grew 19.5% year-over-year, reaching $21.7 million. This strong demand is a primary reason for the company's success. Management notes all-time highs in active prescribers and its patient pipeline, which signal sustained future demand.
Due to these results, NeuroPace raises its revenue guidance for 2026. The company now expects its RNS System revenue to grow between 21% and 23% for the full year. This updated forecast reflects management's confidence in its commercial execution and the continued adoption of its technology in the market.
While the company reports a GAAP net loss of $6.7 million, its adjusted EBITDA loss improves to $3.3 million from $4.1 million a year prior. Adjusted EBITDA provides a view of operational performance by excluding items like interest and taxes. This improvement suggests the core business is becoming more efficient.
|
VRAX§>
Virax Biolabs Group Limited
|
$0.24
53.09%
|
|
WGRX§>
Wellgistics Health, Inc.
|
$0.17
108.38%
|
|
AIM§>
AIM ImmunoTech Inc.
|
$0.41
61.26%
|
|
SBFM§>
Sunshine Biopharma, Inc.
|
$0.51
79.51%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$9.95
7.80%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$5.05
1.81%
|
|
PMI§>
Picard Medical, Inc.
|
$0.17
7.06%
|
|
GOVX§>
GeoVax Labs, Inc.
|
$2.21
79.67%
|
|
NXXT§>
NextNRG Inc.
|
$0.41
46.22%
|
|
CREG§>
Smart Powerr Corp.
|
$0.62
30.59%
|